Sweet TnT Magazine Trinidad and Tobago Culture
Children with high cholesterol, aged 5 to 11, with homozygous familial hypercholesterolemia (HoFH), an ultra-rare inherited condition, can now be treated with Evkeeza® (evinacumab-dgnb) since the US Food and Drug Administration (FDA) has extended the approval of it to young children. The announcement was made by Regeneron Pharmaceuticals, Inc. (NASDAQ: …
Read More »Children with high cholesterol rare type can be treated with Evkeeza now FDA approved
You must be logged in to post a comment.